Overview of the complete guideline development workflow
| Project | Content |
| A. Preparatory work | |
| 1 Determine the requirements of the guideline | |
| 1.1 Develop new guideline | |
| 1.2 Extend existing guideline | |
| 1.3 Use existing guidelines directly | |
| 2 Review the literature | |
| 2.1 Identify existing relevant guideline | |
| 2.2 Find evidence to show the quality of the published research report | |
| 2.3 Identify potential biased information in the current study | |
| 3 Obtain sponsorship for the development of reporting guideline | |
| B. Before the meeting | |
| 4 Identify participants | |
| 5 Delphi survey | |
| 6 Develop a list of items for face-to-face meeting discussion | |
| 7 Prepare for a face-to-face meeting | |
| 7.1 Determine the size and time required for face-to-face meeting | |
| 7.2 Arrange the logistics of the meeting | |
| 7.3 Set the agenda of the meeting | |
| 7.3.1 Report the relevant background of the project | |
| 7.3.2 Share the results of the Delphi survey with participants | |
| 7.3.3 Invite the chairman of the meeting | |
| 7.4 Prepare materials for participants | |
| 7.5 Prepare the meeting record | |
| C. Face-to-face consensus Meeting | |
| 8 The expert group will discuss the relevant evidence and results prepared before the presentation by the members of the research group | |
| 8.1 Discuss the basic principles of determining the items to be comprised | |
| 8.2 Discuss the making of flow chart | |
| 8.3 Discuss the relevant document production strategy; determine the personnel that should be comprised in each link and the author of the final research results | |
| 8.4 Discuss the knowledge transformation strategy of the report guide | |
| D. After the meeting | |
| 9 Disseminate the reporting guideline | |
| 10 Develop explanatory document | |
| 11 Determine the publishing strategy | |
| 11.1 We will consider publishing simultaneously in a journal | |
| E. Evaluation | |
| 12 Submit the guideline to the National Health Commission of the People’s Republic of China | |
| 13 The guidelines will be translated into multiple languages and recommend it to national clinical trial management agencies | |
| 14 Recommend the guidelines to the China Clinical Trials Registration Platform and WHO Clinical Trials Registration Institution | |
| 15 The guideline will be presented at conferences and published in journal | |
| 16 Establish a dynamic feedback mechanism and evaluate the guideline | |